Frankfurt
12.05.26 | 08:07
0,003 Euro
0,00 % 0,000
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,003 | 0,051 | 12.05. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | KDventures AB: KDventures' Annual General Meeting 2026 | 91 | GlobeNewswire (Europe) | STOCKHOLM, SWEDEN - May 12, 2026. KDventures AB (publ) ("KDventures" or the "Company") held the Annual General Meeting on May 12, 2026. The shareholders have had the right to exercise their voting rights... ► Artikel lesen | |
| 30.04. | KDventures AB: Interim Report - January-March 2026 | 102 | GlobeNewswire (Europe) | STOCKHOLM - 30 April 2026. KDventures AB (Nasdaq Stockholm: KDV) today publishes its Interim Report January-March 2026. The full report is available on the Company's website.
"We started 2026 by strengthening... ► Artikel lesen | |
| 09.04. | KDventures AB: KDventures' portfolio company SVF Vaccines partners with Touchlight to accelerate SVF-001 toward clinical development | 139 | GlobeNewswire (Europe) | STOCKHOLM, Sweden, April 9, 2026. KDventures AB (Nasdaq Stockholm: KDV) today announces that its portfolio company SVF Vaccines has entered into a collaboration with Touchlight, a biotechnology company... ► Artikel lesen | |
| 11.03. | KDventures AB: KDventures' portfolio company AnaCardio extends IP protection for AC01 until the 2040s with new US patent approval | 166 | GlobeNewswire (Europe) | STOCKHOLM, SWEDEN March 11, 2026. KDventures AB (Nasdaq Stockholm: KDV) today announces that its portfolio company AnaCardio has received approval for a US patent covering the use of AC01 for the treatment... ► Artikel lesen | |
| 03.03. | KDventures AB: KDventures announces that Organon has discontinued the development of the previous portfolio company Forendos' drug candidate for PCOS | 363 | GlobeNewswire (Europe) | STOCKHOLM, Sweden, March 3, 2026. KDventures AB (Nasdaq Stockholm: KDV) today announces that Organon has discontinued the development of a preclinical drug candidate for polycystic ovarian syndrome... ► Artikel lesen | |
| 27.02. | Change of number of shares and votes in KDventures AB | 1 | GlobeNewswire (USA) | ||
| 24.02. | KDventures AB: KDventures's portfolio company SVF Vaccines announces that the intended merger with Novakand Pharma will not be carried out following negative decision from Nasdaq | 332 | GlobeNewswire (Europe) | STOCKHOLM, Sweden, February 24, 2026. KDventures AB (Nasdaq Stockholm: KDV) announces that the planned reversed acquisition of the portfolio company SVF Vaccines by Novakand Pharma will not be completed... ► Artikel lesen | |
| 13.02. | KDventures AB: Year-end Report - January-December 2025 | 244 | GlobeNewswire (Europe) | STOCKHOLM - 13 February 2025. KDventures AB (Nasdaq Stockholm: KDV) today publishes its Year-end Report January-December 2025. The full report is available on the Company's website. "A stronger financial... ► Artikel lesen | |
| KDVENTURES Aktie jetzt für 0€ handeln | |||||
| 12.02. | KDventures AB (publ): KDventures AB (publ) carries out a directed issue of shares to guarantors in connection with the completed rights issue | 259 | GlobeNewswire (Europe) | NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, JAPAN, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH KOREA, SOUTH... ► Artikel lesen | |
| 10.02. | KDventures AB (publ): KDventures' portfolio company SVF Vaccines appoints Raheleh Nassaji as Chief Executive Officer | 310 | GlobeNewswire (Europe) | STOCKHOLM, Sweden, 10 February 2026. KDventures AB (Nasdaq Stockholm: KDV) announces that its portfolio company SVF Vaccines has appointed Raheleh Nassaji as Chief Executive Officer to lead the transition... ► Artikel lesen | |
| 09.02. | Change of issuer name and symbol for Karolinska Development AB | 310 | GlobeNewswire | As from February 10, 2026, Karolinska Development AB will change issuer name and symbol.
Old issuer name: Karolinska Development AB
New issuer name: KDventures AB
Old symbol: KDEV
New symbol: KDV
ISIN... ► Artikel lesen | |
| 06.02. | Karolinska Development AB (publ): Karolinska Development's portfolio company SVF Vaccines and Novakand Pharma enters into a reverse acquisition agreement | 247 | GlobeNewswire (Europe) | STOCKHOLM, Sweden, February 6, 2026. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company SVF Vaccines has entered into a reverse acquisition agreement with Novakand... ► Artikel lesen | |
| 28.01. | Karolinska Development AB: Karolinska Development AB (publ) announces the outcome of the rights issue and change of the company name to KDventures AB | 351 | GlobeNewswire (Europe) | NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, JAPAN, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH KOREA, SOUTH... ► Artikel lesen | |
| 23.01. | Karolinska Development AB (publ): Karolinska Development AB receives additional guarantee commitments in ongoing rights issue | 453 | GlobeNewswire (Europe) | NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, JAPAN, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH KOREA, SOUTH... ► Artikel lesen | |
| 21.01. | Karolinska Development AB (publ): Karolinska Development's portfolio company Dilafor signs binding term sheet with Exeltis for a license agreement regarding tafoxiparin | 241 | GlobeNewswire (Europe) | STOCKHOLM, SWEDEN - January 21, 2026. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Dilafor has signed a binding term sheet with Exeltis, a global Women's... ► Artikel lesen | |
| 13.01. | The subscription period in Karolinska Development AB (publ)'s rights issue begins today | 1 | GlobeNewswire (USA) | ||
| 12.01. | Listing of subscription rights and paid subscription shares of Karolinska Development AB | 337 | GlobeNewswire | With effect from January 13, 2026, the subscription rights of Karolinska Development AB will be traded on the list for Equity rights. Trading will continue up until and including January 22, 2026.
... ► Artikel lesen | |
| 09.01. | Karolinska Development AB (publ) announces publication of information document in connection with upcoming rights issue | 255 | GlobeNewswire (Europe) | NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, JAPAN, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH KOREA, SOUTH... ► Artikel lesen | |
| 08.01. | Karolinska Development AB (publ): Karolinska Development's Extraordinary General Meeting 2026 | 370 | GlobeNewswire (Europe) | STOCKHOLM, SWEDEN - January 8, 2026. Karolinska Development AB (publ) ("Karolinska Development" or the "Company") held an Extraordinary General Meeting on January 8, 2026, at which the shareholders... ► Artikel lesen | |
| 07.01. | XFRA CAPITAL ADJUSTMENT INFORMATION - 07.01.2026 | 740 | Xetra Newsboard | Das Instrument SFTU US83404D1090 SOFTBANK GR.UNS.ADR1/2/ON EQUITY wird cum Kapitalmassnahme gehandelt am 07.01.2026 und ex Kapitalmassnahme am 08.01.2026 The instrument SFTU US83404D1090 SOFTBANK GR.UNS.ADR1/2/ON... ► Artikel lesen |
1 2 Weiter >>
40 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| NORTHPALM CAPITAL | 0,061 | -40,76 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 08.05.2026 | Das Instrument RVY DK0061152170 ROVSING AS IN. DK 10 EQUITY wird ex Kapitalmassnahme gehandelt am 08.05.2026 The instrument RVY DK0061152170 ROVSING AS IN. DK 10 EQUITY is traded ex capital adjustment... ► Artikel lesen | |
| NAKIKI | 0,345 | -4,17 % | EQS-PVR: Nakiki SE: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Nakiki SE
Nakiki SE: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
07.05.2026 / 18:03... ► Artikel lesen | |
| AUXLY CANNABIS | 0,082 | -2,84 % | Auxly Cannabis Group Inc: Auxly Cannabis to release Q1 results on May 14 | ||
| CR ENERGY | 0,073 | +1,10 % | MPH Health Care: CR-Energy-Insolvenz sorgt 2025 für Verlust | Die MPH Health Care AG weist für das Geschäftsjahr 2025 einen Jahresfehlbetrag von 29,3 Millionen Euro aus, nach einem Jahresüberschuss von 32 Millionen Euro im Vorjahr. Das EBIT drehte auf minus 28... ► Artikel lesen | |
| ARGO BLOCKCHAIN | 0,012 | -0,83 % | Removal - Argo Blockchain PLC | DJ Removal - Argo Blockchain PLC
Financial Conduct Authority (-)
Removal - Argo Blockchain PLC
12-Dec-2025 / 08:00 GMT/BST
=----------------------------------------------------------------------------------------------------------------------... ► Artikel lesen | |
| PINE TECHNOLOGY | 0,027 | 0,00 % | PINE TECH (01079): NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED SHAREHOLDERS - NOTICE OF PUBLICATION OF 2026 INTERIM REPORT | ||
| AIFINYO | 1,100 | +57,14 % | DEWB: Wertberichtigungsbedarf bei aifinyo belastet Jahresergebnis | Nächste Gewinnwarnung nun auch bei der Deutsche Effecten- und Wechsel-Beteiligungsgesellschaft AG (ISIN: DE000 A41YCR 9): So werde das 2025er-Jahresergebnis durch eine außerplanmäßige Abschreibung im... ► Artikel lesen | |
| INTELLABRIDGE TECHNOLOGY | 0,009 | -18,18 % | Intellabridge Technology Corporation: Intellabridge Provides Strategic Update and Transition to Spark Plug Partnership | Vancouver, British Columbia--(Newsfile Corp. - December 1, 2025) - Intellabridge Technology Corporation (CSE: KASH) (OTC Pink: KASHF) (the "Company"), an impact-driven technology company, today announced... ► Artikel lesen | |
| XTM | 0,005 | -100,00 % | XTM Inc.: XTM Commences Court-Approved Sale and Investment Solicitation Process with Stalking Horse Bid | TORONTO, April 28, 2026 /CNW/ - XTM Inc. (OTCQB: XTMIF) (CSE: PAID) (the "Company") and its subsidiary, Everyday People Payments Inc. (together, the "XTM Entities")... ► Artikel lesen | |
| NEXTGEN DIGITAL PLATFORMS | 0,074 | -4,90 % | Nextgen Digital Platforms Inc: Nextgen Digital makes director, officer changes | ||
| ALSET AI VENTURES | 0,112 | +0,09 % | Alset AI Ventures Inc.: Alset AI Acquires Chaco Minerals Debenture Adding Approximately $1.3 Million Investment to Balance Sheet to Offset Lyken.AI Receivables and Strengthen Investment Portfolio | Transaction Provides Exposure for Alset AI to Important Critical Minerals in the Global Energy Transition while Improving Lyken.AI's Financial Position as it Pursues Strategic Growth Opportunities VANCOUVER... ► Artikel lesen | |
| TRANSOCEANIC INVESTMENTS | 0,045 | +6,67 % | UTC Overseas, Transoceanic Launch US Gulf Coast Logistics Joint Venture | ||
| CARNEGIE CLEAN ENERGY | 0,031 | -2,50 % | CARNEGIE CLEAN ENERGY LIMITED: Carnegie Selected for US TEAMER Technical Support | ||
| K33 | 0,002 | 0,00 % | Sixty Six Capital Inc.: Sixty Six Capital Announces Closing of Transaction with K33 AB and Board and Management Changes | Toronto, Ontario--(Newsfile Corp. - March 18, 2026) - Sixty Six Capital Inc. (CSE: SIX) ("Sixty Six" or the "Company") announces, further to its press release dated February 17, 2026, the closing... ► Artikel lesen |
KDVENTURES AB gehört der Branche Finanzdienstleistungen an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,003 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu KDVENTURES AB finden Sie auf Wallstreet Online.